Pillar Biosciences Receives CLIA Certification for its Next-Generation Sequencing Clinical Laboratory
Pillar Biosciences Receives CLIA Certification for its Next-Generation Sequencing Clinical Laboratory January 6, 2022 Home > Resources > Press Release > Pillar Biosciences Receives CLIA Certification for its Next-Generation Sequencing Clinical Laboratory NATICK, Mass. – January 6, 2022 – (BUSINESS WIRE) – Pillar Biosciences, an innovative, next-generation sequencing (NGS) solutions, in-vitro diagnostics (IVD) company, today announced that its NGS laboratory, located in Natick, Massachusetts, has passed the onsite inspection and received Clinical Laboratory Improvement Amendment (CLIA) certification from the U.S. Department of Health and Human Services’ Centers for Medicare and Medicaid Services (CMS), as well as the Massachusetts state permit. […]